The earnings report comes on the heels of an expansion effort for the Wakefield, Massachusetts-based company. That same day, Curaleaf announced that it will purchase three Arrow Alternative Care dispensaries in Connecticut.
“In fiscal 2019, the Curaleaf team delivered record results with our organic business growth and recent strategic acquisitions, solidifying our position as the leading cannabis operator in the United States,” Joseph Lusardi, CEO of Curaleaf said in a statement.
Among those record results was adjusted EBITDA of $25.9 million, versus an adjusted EBITDA loss of $10.4 million in 2018.
Curaleaf also reported fourth quarter record total revenue of $75.5 million, …